Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. - Test2 - elhamkhani - TriplyDB

Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.

Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.

http://www.wikidata.org/entity/Q36249780

about

Interaction between Mesenchymal Stem Cells and B-Cells Stem cell therapy to cure type 1 diabetes: from hype to hope.Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes Current stem cell based therapies in diabetes Mechanisms of mesenchymal stem/stromal cell function Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors.Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy.Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers Mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) induce immune modulatory profile in monocyte-derived dendritic cells Adipokines as drug targets in diabetes and underlying disturbances.Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes.CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury.Advances in the cellular immunological pathogenesis of type 1 diabetes Applicability of adipose-derived stem cells in type 1 diabetes mellitus.Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus.Nasal Polyp-Derived Mesenchymal Stromal Cells Exhibit Lack of Immune-Associated Molecules and High Levels of Stem/Progenitor Cells Markers.Mesenchymal stromal cells to halt the progression of type 1 diabetes?Adipose Stem Cell Therapy Mitigates Chronic Pancreatitis via Differentiation into Acinar-like Cells in Mice.Mesenchymal stem cells moderate immune response of type 1 diabetes.The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.Mesenchymal Stromal Cell-Derived Microvesicles Regulate an Internal Pro-Inflammatory Program in Activated Macrophages.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment.

P2860

Q26750859-81A6DCF1-4C56-40F9-888F-8B32F690CA61 Q26823294-980EBD8F-C632-48E2-B8AF-E35AC4444F5F Q26864580-97E78E85-AFC1-4355-B979-50696F46538A Q27026892-974155F6-DB50-4DC4-9D3E-8894950168E2 Q27334841-EA95A207-F539-4DB8-84F9-1D3F1C3EBDD5 Q28071490-69D6253E-56F2-48ED-8E47-C69F1D853EE9 Q28074914-B3ADE7B3-9D0C-4247-A24C-DA670B4D27BF Q28079649-B7495B13-2D27-4C79-B479-0647FC08FF7B Q28085040-59C12CED-0C0E-4C7C-8E67-843193CFD8CF Q28085080-826DF308-C6C2-4486-BDF0-BA9BBB610B49 Q28534075-4A364284-797C-40E8-A2ED-57AB2FDDDA16 Q33779347-1E559B51-2F8B-432F-9ADC-203185353C8D Q33846336-14835B7E-D6F8-46B8-A4C2-5453BB2737EE Q33902006-2F7EFD3D-01DC-41B3-86A5-59126631D6DB Q34245510-C70C4CCF-5B82-4F04-970C-AEE4EFF67B6C Q34456751-336B3CE1-3070-4AC9-BC93-7A7D2835D9F4 Q35171621-939D2B1D-8888-4050-BC5B-7D64CF8B0978 Q35415815-374CD299-642F-489B-B27C-BF5900DB4816 Q35609423-CEC6C85C-72AD-4214-8DD2-BE2A66775678 Q35660316-0729EDD0-6A26-4C64-A230-AD6787F809D0 Q35998318-4C94CC92-18C3-40AF-9E15-950E7B3D004C Q36201380-294CC8F3-D979-47AB-9747-EE7A6FFAD45F Q36234988-EDFBBA55-6FC3-4021-BE97-3D901536D987 Q36262326-F64B536C-A2B5-42DD-9C1C-D89EE46DE150 Q36506550-0D34C988-E0FA-4883-A902-0E6CED7A713F Q37089931-D7F4D565-F0C3-464C-A1FD-4BBBA43438EF Q37204124-675ADAF4-60EA-4195-A51C-4C5C68A6E254 Q37692502-B2CAA030-C74E-40A4-9D22-28533955D5F7 Q38172498-9D144316-3356-424C-8972-3FEE975C0D31 Q38195946-3BE868A6-C8EB-4D1C-9AE2-918936272596 Q38332629-8C88B4A8-428C-48AE-A397-55887929E0AC Q38387552-440DC210-A326-4B7C-8B02-ECA038AB5872 Q38437028-62A18591-6731-4C03-BF10-5981D49E95B7 Q38499617-591EDA5A-A799-48DB-A1BD-C7BB0A554FA4 Q38636311-BA577DA5-C590-4CAE-AA14-A5AB9EBD72EA Q38977465-FB057CF1-0D05-4337-8A51-FDCEF1B27488 Q39386163-60DBA484-02EF-4F0A-BADA-87902D603B5E Q41174179-411F9921-A6E7-4DAB-B13F-0478D53ABB55 Q41196008-5EB86F3C-0945-4E0C-90B2-E0394B878779 Q42000663-C5633D4D-4598-4724-AE5A-16FC660B4AB8

P2860

Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.

http://www.wikidata.org/entity/Q36249780

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Immune regulatory properties o ...... erimental autoimmune diabetes.

@ast

Immune regulatory properties o ...... erimental autoimmune diabetes.

@en

type

label

Immune regulatory properties o ...... erimental autoimmune diabetes.

@ast

Immune regulatory properties o ...... erimental autoimmune diabetes.

@en

prefLabel

Immune regulatory properties o ...... erimental autoimmune diabetes.

@ast

Immune regulatory properties o ...... erimental autoimmune diabetes.

@en

P1433

Q36249780-45BC56C1-E3BE-4C8F-9A39-539CA9914687

P1476

Q36249780-1B60409C-79D9-4577-A184-E945C887DBE9

P2093

Q36249780-225DA46C-5A93-4792-A206-716584D29990

Q36249780-332737FE-FE7E-4CF4-AC2B-DDEC7D0C2A00

Q36249780-3AFA3413-DDCC-4ACF-81ED-29D4AD751A56

Q36249780-77190481-34BC-4F83-9216-474FB221AD9A

Q36249780-A1A5E410-65BF-464B-87F4-A7BF9A273A76

Q36249780-B97096E2-78EC-44DA-BD95-A8CC13DF12B7

P2860

Q36249780-00A417B3-E1BB-417E-84F8-36CA7DB46CF2

Q36249780-04EADDE4-5C05-4E3F-AC55-966C2EA2E920

Q36249780-0938DC27-89C8-42A5-BD1D-53877AFBF06E

Q36249780-11A86BE2-0D5C-433C-9BEC-FE0E1FEC201D

Q36249780-172736BE-DFFF-4315-891E-DAA0160EEB6F

Q36249780-1C0587D3-A2AA-469E-9921-8939158E99AE

Q36249780-1F6EFCED-C760-4E0F-8CFA-249729F9CC9E

Q36249780-1F7AEE45-C5B4-4014-A323-15C32B4601C6

Q36249780-314846A4-7E97-473C-BE36-9A705D2179AF

Q36249780-38970F86-0821-4A57-A877-4D2E8BB877CF

P304

Q36249780-211D6D87-FF77-4FBE-A96D-D800FB14FE59

P31

Q36249780-9312764F-743B-47B5-A378-F758E0ADFE4F

P356

Q36249780-A5F3ACC7-2F20-421A-81DC-1690E3E70DF0

P407

Q36249780-EA20EF27-9F3C-4556-A766-4EE64892EF44

P433

Q36249780-51DD6AB7-1483-47CB-9AF9-E7C5739A907C

P478

Q36249780-44CAC927-1227-468E-A709-3FFFF2232411

P50

Q36249780-00234555-B1B0-4FFF-AA28-0A9EB5F0FC91

Q36249780-073F324C-7E8C-40CA-BC54-614B09389A8F

Q36249780-A8B349EA-78F0-4A8D-9B97-457D99BFE692

Q36249780-AD7057BA-D9B4-4207-ACB0-2AE9A5C6D009

P577

Q36249780-F266DD0E-D2E9-48DD-98F4-EFDC89A86C34

P5875

Q36249780-5E338534-FE03-49E1-AA46-F890FDBE3CBB

P698

Q36249780-CF3F9F22-7DE3-4954-9A1E-9F71CC7CAE49

P932

Q36249780-2B444197-43B4-49BD-98CC-FF8708452320

P356

P1433

P1476

Immune regulatory properties o ...... perimental autoimmune diabetes

@en

P2093

Alexandre S Basso

http://www.w3.org/2001/XMLSchema#string

Alvaro Pacheco-Silva

http://www.w3.org/2001/XMLSchema#string

Carla S R Moreira-Sá

http://www.w3.org/2001/XMLSchema#string

Cláudia S Cunha

http://www.w3.org/2001/XMLSchema#string

Meire I Hiyane

http://www.w3.org/2001/XMLSchema#string

Pedro M M Moraes-Vieira

http://www.w3.org/2001/XMLSchema#string

P2860

The PD-1 pathway in tolerance and autoimmunity

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

Human mesenchymal stem cells modulate B-cell functions

Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

P304

2534-2545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB11-0844

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Ênio José Bassi

Pedro M M M Vieira

Danilo C Almeida

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225296232

http://www.w3.org/2001/XMLSchema#string

P698

22688334

http://www.w3.org/2001/XMLSchema#string

P932

3447906

http://www.w3.org/2001/XMLSchema#string